Theralase Technologies Inc. V.TLT

Difficult-to-value$-TLT...

[wildbird1]

In a March 12,2022 interview DrMcFarland said " TLT patients have already failed other forms(with an s) of cancer therapy and their only option at this time is to have their bladder removed ".

For TLT cancer patients.
-Surgery doesn't work...
-BCG doesn't work...
-Chemotherapy & Radiotherapy doesn't work...
-Nothing works.

If TLT does negotiate a JV or a buyout deal with a Big Pharma, the selling points for TLT will be many.
1)TLT cancer treatment has a very high CR% (optimized patients).
2)TLT cancer treatment has almost no side effects.
3)TLT cancer treatment can cure patients that surgery couldn't cure.
4)TLT cancer treatment can cure patients that BCG couldn't cure.
5)TLT cancer treatment can cure patients that Chemotherapy & Radiotherapy couldn't cure.
6) TLT cancer treatment will be adapted to cure other cancers, GBM (Glio blastoma multiforme), NSCLC (Non-Small Cell Lung Cancer).
7)Cocid-19 Vaccine.

Because of all the above it is almost impossible to place a $ value on a Big Pharma JV or a Buyout deal.
But we can certainly say that it does augur very well in favor of TLT.

For now let the manipulation play the SP, just sit tight and wait for the next CR% report that will continue to be better and better, and will add more value$ to TLT.

[BlueFranky]

YE$$.... What wildbird1 said!

[thadeush]

Excellent points. I'm no health expert, but I'd imagine the patients TLT is currently treating after other treatments did not cure/help, from wildbird1's points 3, 4, and 5, are already immunocompromised because they are exhausted from the side effects of previous treatment regimens. Yet T:T is still getting excellent results. Imagine the results TLT will get when they finally have the

[CancerSlayer]

  If TLT's higher efficacy & safety rates pan out at completion of the study, I'd also expect there will be some off-label use of TLT's ACT as a first line option, especially considering our protocol requires only two treatments.   One would expect a push for earlier use of our ACT when you consider the high failure rate of BCG in high-risk NMIBC (recurrence &

[CancerSlayer]

  Forgot to mention...in addition to entering future combo trials, I anticipate there will eventually be much broader investigation of our ACT in the form of more extensive randomized clinical trials, comparing our ACT as a potential first-line option against the standard of care....but we can leave that expense to our future partner or Pharma ; ).  All of the above JMHO.

[wildbird1]

A little complementary note about Chemotherapy. As claimed in this article healthline.com/health/chemotherapy#procedure Under Long-term effects... Chemotherapy long-term effects could include...damage to the -Heart -Kidneys -Lungs -Nerves -Reproductive organ -There is also a chance of developing a second cancer as a results of the chemotherapy treatment itself. Those are all frightening Long